BBO-10203   Click here for help

GtoPdb Ligand ID: 13703

Synonyms: compound 508 [WO2023154282A1]
Compound class: Synthetic organic
Comment: BBO-10203 is an oral PI3Kα:RAS interaction inhibitor. It docks at the RAS binding domain of PI3Kα, blocking interactions with all RAS isoforms, but does not disrupt PI3Kα activity. This is a mechanism that has antitumour potential.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/). All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 9
Hydrogen bond donors 0
Rotatable bonds 9
Topological polar surface area 107.63
Molecular weight 640.7
XLogP 3.12
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES C=CC(=O)N1CCN2C(=CC(=N2)C3=C(C4=C(C=C(C=C4F)F)OCCOC)C5=C(C=CS5)C(=N3)C6=CC7=C(C=C6)N(C)N=C7)[C@H]1C
Isomeric SMILES O=C(C=C)N1[C@H](C)C2=CC(C3=C(C4=C(F)C=C(F)C=C4OCCOC)C=5SC=CC5C(C6=CC=C7N(C)N=CC7=C6)=N3)=NN2CC1
InChI InChI=1S/C34H30F2N6O3S/c1-5-29(43)41-9-10-42-27(19(41)2)17-25(39-42)33-31(30-24(36)15-22(35)16-28(30)45-12-11-44-4)34-23(8-13-46-34)32(38-33)20-6-7-26-21(14-20)18-37-40(26)3/h5-8,13-19H,1,9-12H2,2-4H3/t19-/m1/s1
InChI Key CHKHXOHYIIZDNQ-LJQANCHMSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
No information available.
Summary of Clinical Use Click here for help
BBO-10203 is being evaluted in clinical trial to determine safety and efficacy in a range of advanced solid tumour types. The first clinical study will evaluate BBO-10203 alone and in combination with the anti-HER2 monoclonal therapy trastuzumab.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT06625775 Dose Escalation and Expansion of BBO-10203 in Advanced Solid Tumors (BREAKER-101) Phase 1 Interventional TheRas, Inc., d/b/a BridgeBio Oncology Therapeutics